微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 7.64% | 26.49% | 90.05% | 41/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 4.02% | 125.84% | 120.88% | 52/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.82% | 73.33% | -65.07% | 66/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 5.21% | 714.06% | -13.74% | 61/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 6.04% | 175.8% | 239.33% | 56/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.78% | 36.92% | 69.52% | 90/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.05% | -41.99% | 64.06% | 91/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 0.64% | -91.89% | -70.78% | 106/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.19% | -72.8% | 68.46% | 94/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.3% | -72.04% | -28.18% | 101/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.81% | -48.43% | -77.06% | 65/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 7.89% | -32.68% | -1.99% | 59/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 8.05% | -57.43% | 73.12% | 53/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 4.65% | -16.06% | 32.48% | 60/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.51% | -31.98% | -70.05% | 31/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 11.72% | 31.98% | -38.02% | 44/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 18.91% | 116.86% | 241.34% | 7/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 5.54% | 63.91% | 7.36% | 46/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 5.16% | 121.46% | -41.89% | 12/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 8.88% | 34.95% | 1.83% | 65/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 8.72% | 24.22% | 157.99% | 42/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 3.38% | 15.36% | 45.06% | 67/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.33% | 12.56% | -64.59% | 49/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 6.58% | -34.85% | -6.27% | 72/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 7.02% | -31.18% | 139.59% | 47/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 2.93% | -43.55% | 41.55% | 69/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.07% | -46.23% | -79.5% | 54/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 10.1% | -62.85% | -0.98% | 50/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 10.2% | -57.94% | 96.53% | 28/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 5.19% | -69.07% | 34.81% | 41/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.85% | 2% | -85.84% | 14/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 27.19% | -37.12% | 12.12% | 7/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 24.25% | 2% | 44.52% | 2/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 16.78% | 2% | -61.19% | 1/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2015-12-31 | 43.24% | -26.12% | -26.12% | 3/160 | 11.35% | 贝达药业 | 16.78% | 行业排名> |